Global Picrocrocin Market Strategic Research Report

Scope of the Report

The global Picrocrocin market size is predicted to grow from US$ 13.21 million in 2025 to US$ 19.57 million in 2032; it is expected to grow at a CAGR of 5.8% from 2026 to 2032.

Picrocrocin is a monoterpene glycoside precursor of safranal. It is found in the spice saffron, which comes from the crocus flower. Picrocrocin has a bitter taste, and is the chemical most responsible for the taste of saffron. Picrocrocin is one major compounds of saffron (Crocus sativus L. stigma), responsible for the bitter taste of saffron and a molecular marker of this spice, whose taste cannot be imitated from other spices or seasonings, and it can serve to identify true saffron. Picrocrocin displays same antitumor activity that have great potential for the prevention and treatment of various cancers through affecting cellular DNA and RNA synthesis and free radical scavenging activities of cancer.

As one of three major bioactive components of saffron, compared with crocin and safranal, the other medicinal value of picrocrocin such as anti-microbial, carminative, sedative, emmenagogue and so on, deserved to further research.

Global key players of Picrocrocin include Aladdin Biochemical Technology, Biosynth, J&K Scientific, Bolise, Phytolab, etc. The top five players hold a share over 33%.

Europe is the largest market, has a share about 23%, followed by China and Mid East & Africa, with share 20% and 15%, separately.

In terms of product type, 98% Purity is the largest segment, occupied for a share of 49%, and in terms of application, Pharmaceutical has a share about 65 percent.

This report presents a comprehensive overview of the global Picrocrocin market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Purity

• 98% Purity
• 99% Purity
• Others

Segment by Application

• Pharmaceutical
• Food
• Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Picrocrocin market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Pharmaceutical, Food, Others evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact